[Skip to Navigation]
September 1984

Laser Trabeculoplasty-Reply

Author Affiliations

San Diego

Arch Ophthalmol. 1984;102(9):1268. doi:10.1001/archopht.1984.01040031028012

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In Reply.  —We thank Dr Lewis for his interesting observations. Our patients were on maximum-tolerated medical therapy, which in most cases included an oral agent and either epinephrine or dipivefrin. All subjects in our investigation, with two exceptions, were also receiving either pilocarpine or carbachol and timolol maleate. One subject had asthma, which precluded the administration of timolol and one subject had a moderate cataract, which precluded the administration of miotics. Eleven patients were black and six were white. Although our investigation of a limited number of patients was not designed to assess the influence of medication and race on fluorescein leakage, we did not find any differences related to these groups. Assessment of a larger number of subjects may provide statistically valid data in this regard.

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution